Headquartered in Princeton, NJ Fiscal year ends December NASDAQ: IART integralife.com
Integra LifeSciences Holdings Corporation (Nasdaq: IART) is a global medical technology company focused on neurosurgery and tissue reconstruction. The company operates through two primary segments: Specialty Surgery (approximately 70% of revenues), which includes neurosurgery products such as CereLink, Certas Plus, Bactiseal, and DuraSeal, as well as surgical instruments and ENT products including sinus balloons; and Tissue Reconstruction (approximately 30% of revenues), which offers wound reconstruction solutions including DuraSorb, PriMatrix, MicroMatrix, and Integra Skin, along with Corporate Partnerships (formerly Private Label) business. The company serves healthcare professionals globally with a portfolio of differentiated medical technologies used in life-saving surgical procedures. Updated
With consumer sentiment sitting at 53.3 in March 2026, deep in pessimistic territory, retail investors are hunting for defensive names that can grow even as households tighten budgets. Healthcare keeps that promise.…
With a market rotation underway, where should investors seeking opportunities in health care be looking? Analysts have high expectations for Alphatec.
Friday's top analyst upgrades and downgrades included Abercrombie & Fitch, Amazon.com, AMC Entertainment, Analog Devices, Discover Financial Services, Estee Lauder, Foot Locker, International Flavors & Fragrances, NetApp, Nvidia, Peloton Interactive and Xcel…
The futures are positive after a strong risk-on Wednesday that saw all of the major indices close higher. The tailwind for stocks was provided by the June consumer-price-index numbers that saw inflation…
Thursday's top analyst upgrades and downgrades included Antero Resources, AutoZone, Coterra Energy, Dollar General, Eli Lilly, First Horizon, Infosys, Owens Corning, Palo Alto Networks, Range Resources, Southwestern Energy, Toast, Urban Outfitters and Workday.
Wednesday's top analyst upgrades and downgrades included Chevron, Cleveland-Cliffs, Infosys, Knight-Swift Transportation, Microsoft, Nucor, Salesforce, Steel Dynamics, Wheaton Precious Metals and Zoom Video Communications.
Wednesday’s additional top analyst upgrades and downgrades included Humana, Nvidia, Thor and more.
Thursday's top analyst upgrades and downgrades included AT&T, Boeing, ConocoPhillips, Gilead Sciences, Illumina, Lam Research, Raytheon Technologies and Yum Brands.
The top analyst upgrades, downgrades and initiations seen on Thursday included AbbVie, Agilent Technologies, Albermarle, Apple, Boeing, Cheniere Energy, First Solar, HCA, LabCorp, Lumber Liquidators and Teva Pharmaceutical.
A Credit Suisse analyst issued a broad new sector coverage for medical devices and related companies with strong Outperform ratings on Tuesday.
The top analyst upgrades, downgrades and initiations seen on Tuesday included Abbott Laboratories, Albermarle, Boston Scientific, BP, Embraer, Intuit, Marathon Oil and Norfolk Southern.
The top analyst upgrades, downgrades and other research calls from Monday include BlackRock, Capital One, Kroger, Nordstrom, Starbucks and Wells Fargo.
The top analyst upgrades, downgrades and other research calls from Tuesday include Abbott Labs, Delphi, Lululemon, Netflix, Nordstrom, Sirius XM, Disney and Windstream.
Argus likes Integra’s strong growth prospects and its ability to execute on acquisition and mergers that help move the company's needle on growth in revenue and earnings.
Jon C. Ogg Biotech and pharma companies were on the move Wednesday. A few of the smaller caps made tremendous gains on the day, while a couple of the major firms saw massive volume and…
Integra LifeSciences Holdings Corporation (Nasdaq: IART) is a global medical technology company focused on neurosurgery and tissue reconstruction.
The Wall Street consensus 12-month price target for IART is $15.67.
